Product NDC: | 51672-4109 |
Proprietary Name: | Ondansetron Hydrochloride |
Non Proprietary Name: | Ondansetron Hydrochloride |
Active Ingredient(s): | 8 mg/1 & nbsp; Ondansetron Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51672-4109 |
Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077729 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110328 |
Package NDC: | 51672-4109-8 |
Package Description: | 1 BLISTER PACK in 1 CARTON (51672-4109-8) > 3 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Code | 51672-4109-8 |
Proprietary Name | Ondansetron Hydrochloride |
Package Description | 1 BLISTER PACK in 1 CARTON (51672-4109-8) > 3 TABLET, FILM COATED in 1 BLISTER PACK |
Product NDC | 51672-4109 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ondansetron Hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20110328 |
Marketing Category Name | ANDA |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Substance Name | ONDANSETRON HYDROCHLORIDE |
Strength Number | 8 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |